In addition, preeclampsia is associated with an increase in placental anti-angiogenic agents (sFlt1 or sVEGFR-1) and endoglin because the administration of these agents to pregnant mice causes preeclampsia (1). This evidence concerns the gene ENG and preeclampsia.